드러그인포 약품 상세정보

허가정보

항목

내용

청구코드(KD코드)
비급여점검코드
상한금액

657400090 [보험코드에 따른 약품기본정보 직접조회]
[비급여]
[상병코드조회]
[질병코드집 다운로드] [우리집건강주치의 바로가기]

빠른조회


요약정보	[효능] [용법] [금기] [신중투여] [이상반응]

상세정보	[효능] [용법] [경고] [금기] [신중투여] [이상반응] [일반주의] [상호작용] [임산부] [수유부] [소아] [고령자] [신장애환자] [간장애환자] [적용주의] [과량투여] [임상검사치] [보관] [기타]

제품성상

무색의 방향이 있는 맑은 액 [제형정보 확인]

포장·유통단위

자사포장단위에 따름

포장·코드단위

약품규격	단위	대표코드	표준코드	비고
50밀리리터	1 개	8806574000901	8806574000932
30밀리리터	1 개	8806574000901	8806574000925
45밀리리터	1 개	8806574000901	8806574000918

주성분코드

A68100CLQ [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]

대표코드

8806574000901

보관방법

차광기밀용기, 실온보관(1～30℃)

약리작용

[조회]

효능효과

[적응증 별 검색]

무좀, 백선, 완선
[Drugbank 의 성분정보열람]
[Clotrimazole][Crotamiton][Lidocaine]

용법용량

* 절대 임의복용하지 마시고 반드시 의사 또는 약사와 상담하시기 바랍니다.

[처방약어]
1일 2-3회 적당량을 환부에 분무한다.

[BMI지수 계산] [Body Surface Area 계산] [Cockcroft-Gault GFR 계산] [MDRD GFR 계산]

주요약물 상호작용

[보기]

금기

이 약물에 대하여 과민증이 있었던 환자

신중투여

약이나 화장품등으로 인해 알레르기 증상(예: 발진, 발적, 가려움, 옻 등)을 일으킨 적이 있는 환자
환부가 광범위한 환자
피부 진무름이 심한 환자
유유아
의사의 치료를 받고 있는 환자

이상반응

피부자극, 피부감작, 홍반, 피부박리, 부종, 가려움증, 두드러기 등이 나타날 수 있습니다.

[주요 이상반응정보]

일반적 주의

본제의 사용으로 인해 발진, 발적, 가려움 등의 증상이 나타난 경우에는 사용을 중지하고 의사 또는 약사와 상담하십시오.
2주간 사용하여도 증상의 개선이 보이지 않을 때에는 사용을 중지하고 의사 또는 약사와 상담하십시오.
정해진 용법 용량을 준수하십시오.

임부에 대한 투여

[임부금기 성분 조회]
임신초기 3개월 동안은 이 약물의 유효성이 부작요을 상회할 경우에만 사용하십시오.

적용상의 주의

눈주위나 안과용으로 사용하지 마십시오. 만일 눈에 들어간 경우에는 물로 씻고 즉시 안과의사의 진료를 받으십시오.
이 약은 외용으로만 사용하고 내복하지 마십시오.
습진, 음낭습진 부위에는 사용하지 마십시오
소아에 사용할 경우에는 보호자의 지도감독하에 사용하십시오.
환부 및 그 주위가 청결하지 않는 경우에는 사용하지 마십시오.

보관 및 취급상의 주의

소아의 손이 닿지 않는 곳에 보관하십시오.
직사일광을 피하고 가능한 한 습기가 적은 서늘한 곳에 보관하십시오.
오용을 피하고 품질을 보존하기 위해 다른 용기로 ?기지 마십시오.

Related FDA Approved Drug

기준 성분:MENTHOL
SALONPAS (MENTHOL; METHYL SALICYLATE)
기준 성분:LIDOCAINE
AKTEN (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE (LIDOCAINE)
ALPHACAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ANESTACON (LIDOCAINE HYDROCHLORIDE)
DECADRON W/ XYLOCAINE (DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE)
DENTIPATCH (LIDOCAINE)
DUOCAINE (BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE)
EMBOLEX (DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE)
EMLA (LIDOCAINE; PRILOCAINE)
IONTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LANABIOTIC (BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE)
LARYNG-O-JET KIT (LIDOCAINE HYDROCHLORIDE)
LARYNGOTRACHEAL ANESTHESIA KIT (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE (LIDOCAINE)
LIDOCAINE AND PRILOCAINE (LIDOCAINE; PRILOCAINE)
LIDOCAINE AND TETRACAINE (LIDOCAINE; TETRACAINE)
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
LIDOCATON (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIDODERM (LIDOCAINE)
LIDOPEN (LIDOCAINE HYDROCHLORIDE)
LIDOSITE TOPICAL SYSTEM KIT (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN FORTE (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LIGNOSPAN STANDARD (EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE)
LTA II KIT (LIDOCAINE HYDROCHLORIDE)
OCTOCAINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ORAQIX (LIDOCAINE; PRILOCAINE)
PEDIATRIC LTA KIT (LIDOCAINE HYDROCHLORIDE)
ROCEPHIN KIT (CEFTRIAXONE SODIUM; LIDOCAINE)
SYNERA (LIDOCAINE; TETRACAINE)
TERRAMYCIN (LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE)
XYLOCAINE (LIDOCAINE)
XYLOCAINE 1.5% W/ DEXTROSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 4% PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE 5% W/ GLUCOSE 7.5% (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE DENTAL WITH EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
XYLOCAINE PRESERVATIVE FREE (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE VISCOUS (LIDOCAINE HYDROCHLORIDE)
XYLOCAINE W/ EPINEPHRINE (EPINEPHRINE; LIDOCAINE HYDROCHLORIDE)
ZINGO (LIDOCAINE HYDROCHLORIDE)
기준 성분:CROTAMITON
CROTAN (CROTAMITON)
EURAX (CROTAMITON)
기준 성분:CLOTRIMAZOLE
CLOTRIMAZOLE (CLOTRIMAZOLE)
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE)
GYNE-LOTRIMIN (CLOTRIMAZOLE)
GYNE-LOTRIMIN 3 (CLOTRIMAZOLE)
GYNE-LOTRIMIN 3 COMBINATION PACK (CLOTRIMAZOLE)
GYNE-LOTRIMIN COMBINATION PACK (CLOTRIMAZOLE)
GYNIX (CLOTRIMAZOLE)
LOTRIMIN (CLOTRIMAZOLE)
LOTRIMIN AF (CLOTRIMAZOLE)
LOTRISONE (BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE)
MYCELEX (CLOTRIMAZOLE)
MYCELEX-7 (CLOTRIMAZOLE)
MYCELEX-7 COMBINATION PACK (CLOTRIMAZOLE)
MYCELEX-G (CLOTRIMAZOLE)
TRIVAGIZOLE 3 (CLOTRIMAZOLE)

정보요약

드럭인포 의약품 요약/상세정보

코드 및 분류정보

항목	내용
성분코드	M040131/리도카인 2.00그램 / M219244/엘 멘톨 1.00그램 / M088335/클로트리마졸 1.00그램 / M051499/크로타미톤 5.00그램 /
주성분코드	A68100CLQ [동일한 주성분코드를 가진 오리지날 또는 제네릭 의약품 조회]
대표코드	8806574000901
BIT 약효분류	외용 항진균제 (Antifungals : Skin & Mucous Membrane)
ATC 코드	Imidazole and triazole derivatives / D01AC [코드분류상세설명] [ATC코드예측]
복지부분류코드	265 (기생성 피부질환용제 )
Drugs By Indication	[전체보기]
Drugs By Classification	[전체보기]

제품정보

항목	내용
청구코드(KD코드) 비급여점검코드 상한금액	657400090 [보험코드에 따른 약품기본정보 직접조회] [비급여] [상병코드조회] [질병코드집 다운로드]
제품성상	무색의 방향이 있는 맑은 액 [제형정보 확인]
포장·유통단위	자사포장단위에 따름
보관방법	차광기밀용기, 실온보관(1～30℃)

복약정보

항목

내용

LACTmed 바로가기

[바로가기]

약리작용

유료정보입니다.

복약지도

유료정보입니다.

임부에대한투여

*	전체임신 기간별로 여러등급이 존재할 수 있으며 가장 위험도가 높은 정보만 보여집니다. 단, 복합제의 경우 모든 복합제성분에 대한 임부투여등급이 표시된것은 절대 아니며 표시된것중에 가장 위험도가 높은 정보만 나타납니다.

FDA : C등급
(clotrimazole;crotamiton; )

*	상기 임부투여에 대한 정보는 전산처리 되면서 입력 오류 가능성이 존재합니다. 오류 가능성을 최소화하기 위하여 많은 노력을 기울이고 있으나, 그 정확성에 대하여 확신을 드릴 수 없습니다. 이에 대해 회사는 책임을 지지 않습니다.
*	반드시 공신력 있는 문헌을 다시 한번 참고 하시기 바라며 의사 또는 약사의 판단에 따라 투여여부가 결정되어야 합니다.

신장애, 간장애시
용량조절

유료정보입니다.

Pharmacokinetics

유료정보입니다.

보관상 주의

조제시 주의

심사정보

항목	내용
DUR 관련 고시	[병용연령금기 의약품 / 임부금기 의약품 / 비용효과적 함량 의약품 / 안전성 관련 급여중지 의약품]

학술정보

항목	내용
DUR (의약품사용평가)	병용금기 : 고시된 병용금기 내용은 없습니다. [상호작용/병용금기검색] 연령대금기 : 고시된 연령금기 내용은 없습니다. [연령대금기상세검색]
독성정보	Lidocaine에 대한 독성정보 : 정보보기 출처: 국립독성과학원 독성물질정보DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do
Mechanism of Action	Clotrimazole에 대한 Mechanism_Of_Action 정보 Clotrimazole interacts with yeast 14-α demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the membrane. In this way, clotrimazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Clotrimazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel. Crotamiton에 대한 Mechanism_Of_Action 정보 Crotamiton relieves itching by producing what is called a counter-irritation. As crotamiton evaporates from the skin, it produces a cooling effect. This cooling effect helps to divert your body's attention away from the itching. Lidocaine에 대한 Mechanism_Of_Action 정보 Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Menthol에 대한 Mechanism_Of_Action 정보 Menthol is classified as a calcium channel blocker. Calcium channel blockers are a class of drugs with effects on many excitable cells of the body, like the muscle of the heart, smooth muscles of the vessels or neuron cells. Calcium channel blockers work by blocking voltage-sensitive calcium channels in the heart and in the blood vessels. This prevents calcium levels from increasing as much in the cells when stimulated, leading to less contraction.
Pharmacology	Clotrimazole에 대한 Pharmacology 정보 Clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity, inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Betamethasone and clotrimazole are used together to treat cutaneous tinea infections. In studies in fungal cultures, the minimum fungicidal concentration of clotrimazole caused leakage of intracellular phosphorous compounds into the ambient medium with concomitant breakdown of cellular nucleic acids, and accelerated potassium etflux. Both of these events began rapidly and extensively after addition of the drug to the cultures. The primary action of clotrimazole is against dividing and growing organisms. Crotamiton에 대한 Pharmacology 정보 Crotamiton is usually used to treat pruritis (itching of the skin) caused by scabies or sunburn. Crotamiton relieves itching by producing what is called a counter-irritation. As crotamiton evaporates from the skin, it produces a cooling effect. This cooling effect helps to divert your body's attention away from the itching. Due to this cooling effect it is also effective for the relief of sunburn. The drug is also believed to kill scabies through an unknown mechanism. Lidocaine에 대한 Pharmacology 정보 Lidocaine is an anesthetic agent indicated for production of local or regional anesthesia and in the treatment of ventricular tachycardia occurring during cardiac manipulation, such as surgery or catheterization, or which may occur during acute myocardial infarction, digitalis toxicity, or other cardiac diseases. The mode of action of the antiarrhythmic effect of Lidocaine appears to be similar to that of procaine, procainamide and quinidine. Ventricular excitability is depressed and the stimulation threshold of the ventricle is increased during diastole. The sinoatrial node is, however, unaffected. In contrast to the latter 3 drugs, Lidocaine in therapeutic doses does not produce a significant decrease in arterial pressure or in cardiac contractile force. In larger doses, lidocaine may produce circulatory depression, but the magnitude of the change is less than that found with comparable doses of procainamide. Menthol에 대한 Pharmacology 정보 Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. Menthol's ability to chemically trigger cold-sensitive receptors in the skin is responsible for the well known cooling sensation that it provokes when inhalated, eaten, or applied to the skin. It should be noted that menthol does not cause an actual drop in temperature.
Metabolism	Clotrimazole에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 11A1 (CYP11A1)Cytochrome P450 1A2 (CYP1A2)Cytochrome P450 2D6 (CYP2D6) Crotamiton에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Not Available Lidocaine에 대한 Metabolism 정보 # Phase_1_Metabolizing_Enzyme:Cytochrome P450 1A2 (CYP1A2)Cytochrome P450 2D6 (CYP2D6)
Protein Binding	Clotrimazole에 대한 단백결합 정보 90% Crotamiton에 대한 단백결합 정보 Not Available Lidocaine에 대한 단백결합 정보 60-80% Menthol에 대한 단백결합 정보 Not Available
Half-life	Clotrimazole에 대한 반감기 정보 2 hours Crotamiton에 대한 반감기 정보 Not Available Lidocaine에 대한 반감기 정보 109 minutes Menthol에 대한 반감기 정보 Not Available
Absorption	Clotrimazole에 대한 Absorption 정보 Poorly and erratically absorbed orally, minimal vaginal or topical absorption. Crotamiton에 대한 Absorption 정보 10 % absorbed when applied locally. Lidocaine에 대한 Absorption 정보 Information derived from diverse formulations, concentrations and usages reveals that lidocaine is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent. Menthol에 대한 Absorption 정보 Not Available
Pharmacokinetics	Clotrimazole의 약물동력학자료 흡수 : 외용 : 정상 피부를 통해서는 거의 흡수되지 않는다. 혈중최고농도 도달시간 : Troches : 타액 농도 : 3시간 이내 질 크림 : 질내 농도 : 8-24 시간 이내 질정 : 질내 농도 : 1-2 일 이내 소실 : 대사체로 담즙배설 Lidocaine의 약물동력학자료 효과발현시간 (1회 bolus 용량으로서) : 45-90초 작용지속시간 : 10-25분 분포 (Vd) : 많은 요인에 따라 변화되며, 울혈성 심부전과 간질환에서는 분포용적이 감소됨 단백결합 : 60-80%, α₁-acid glycoprotein과 결합 대사 : 간에서 90% 대사 활성형 대사체인 monoethylglycinexylidide(MEGX)와 glycinexylidide(GX)가 축적되어 중추신경계 독성을 유발할 수 있다. 반감기 (biphasic) : 울혈성 심부전, 간질환, 쇼크, 중증의 신질환에서 증가 초기 : 7-30분 말기 : 영아, 미숙아 : 3.2시간, 성인 : 1.5-2시간 Menthol의 약물동력학자료 소실 : 흡수된 약물은 glucuronide 포합체로서 소변 및 담즙을 통해 배설된다.
Biotransformation	Clotrimazole에 대한 Biotransformation 정보 Hepatic (metabolized to inactive metabolites) Crotamiton에 대한 Biotransformation 정보 Not Available Lidocaine에 대한 Biotransformation 정보 Primarily hepatic.
Toxicity	Clotrimazole에 대한 Toxicity 정보 Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps. Crotamiton에 대한 Toxicity 정보 Not Available Lidocaine에 대한 Toxicity 정보 The oral LD 50 of lidocaine HCl in non-fasted female rats is 459 (346-773) mg/kg (as the salt) and 214 (159-324) mg/kg (as the salt) in fasted female rats. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest. Menthol에 대한 Toxicity 정보 Menthol, DL: ORAL (LD50): Acute: 2900 mg/kg [Rat], 3100 mg/kg [Mouse]. DERMAL (LD50): Acute: 5001 mg/kg [Rabbit].
Drug Interactions	Clotrimazole에 대한 Drug_Interactions 정보 Not Available Crotamiton에 대한 Drug_Interactions 정보 Acetohexamide The beta-blocker decreases the symptoms of hypoglycemiaChlorpropamide The beta-blocker decreases the symptoms of hypoglycemiaCimetidine Cimetidine increases the effect of the beta-blockerClonidine Increased hypertension when clonidine stoppedDisopyramide The beta-blocker increases toxicity of disopyramideGliclazide The beta-blocker decreases the symptoms of hypoglycemiaGlipizide The beta-blocker decreases the symptoms of hypoglycemiaGlisoxepide The beta-blocker decreases the symptoms of hypoglycemiaGlibenclamide The beta-blocker decreases the symptoms of hypoglycemiaGlycodiazine The beta-blocker decreases the symptoms of hypoglycemiaInsulin The beta-blocker decreases the symptoms of hypoglycemiaLidocaine The beta-blocker increases the effect and toxicity of lidocainePropafenone Propafenone increases the effect of beta-blockerRepaglinide The beta-blocker decreases the symptoms of hypoglycemiaRifampin Rifampin decreases the effect of the metabolized beta-blockerTelithromycin Telithromycin may possibly increase metoprolol effectTolazamide The beta-blocker decreases the symptoms of hypoglycemiaTolbutamide The beta-blocker decreases the symptoms of hypoglycemiaAmobarbital The barbiturate decreases the effect of metabolized beta-blockerAprobarbital The barbiturate decreases the effect of metabolized beta-blockerButalbital The barbiturate decreases the effect of metabolized beta-blockerButabarbital The barbiturate decreases the effect of metabolized beta-blockerButethal The barbiturate decreases the effect of metabolized beta-blockerDihydroquinidine barbiturate The barbiturate decreases the effect of metabolized beta-blockerHeptabarbital The barbiturate decreases the effect of metabolized beta-blockerHexobarbital The barbiturate decreases the effect of metabolized beta-blockerMethohexital The barbiturate decreases the effect of metabolized beta-blockerMethylphenobarbital The barbiturate decreases the effect of metabolized beta-blockerPentobarbital The barbiturate decreases the effect of metabolized beta-blockerPhenobarbital The barbiturate decreases the effect of metabolized beta-blockerPrimidone The barbiturate decreases the effect of metabolized beta-blockerQuinidine barbiturate The barbiturate decreases the effect of metabolized beta-blockerSecobarbital The barbiturate decreases the effect of metabolized beta-blockerTalbutal The barbiturate decreases the effect of metabolized beta-blockerCitalopram The SSRI increases the effect of the beta-blockerEscitalopram The SSRI increases the effect of the beta-blockerFluoxetine The SSRI increases the effect of the beta-blockerSertraline The SSRI increases the effect of the beta-blockerParoxetine The SSRI increases the effect of the beta-blockerDihydroergotamine Ischemia with risk of gangreneDihydroergotoxine Ischemia with risk of gangreneErgonovine Ischemia with risk of gangreneErgotamine Ischemia with risk of gangreneMethysergide Ischemia with risk of gangreneVerapamil Increased effect of both drugsHydralazine Increased effect of both drugsDiltiazem Increased risk of bradycardiaEpinephrine Hypertension, then bradycardiaFenoterol AntagonismFormoterol AntagonismIsoproterenol AntagonismOrciprenaline AntagonismPirbuterol AntagonismPrazosin Risk of hypotension at the beginning of therapyProcaterol AntagonismSalbutamol AntagonismSalmeterol AntagonismTerbutaline AntagonismIbuprofen Risk of inhibition of renal prostaglandinsIndomethacin Risk of inhibition of renal prostaglandinsPiroxicam Risk of inhibition of renal prostaglandins Lidocaine에 대한 Drug_Interactions 정보 Not Available Menthol에 대한 Drug_Interactions 정보 Not Available
CYP450 Drug Interaction	[CYP450 Table직접조회]
Food Interaction	Clotrimazole에 대한 Food Interaction 정보 Not Available Crotamiton에 대한 Food Interaction 정보 Not Available Lidocaine에 대한 Food Interaction 정보 Not Available
Drug Target	[Drug Target]
Description	Clotrimazole에 대한 Description 정보 An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [PubChem] Crotamiton에 대한 Description 정보 Crotamiton is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. It is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Lidocaine에 대한 Description 정보 A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. [PubChem] Menthol에 대한 Description 정보 Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils. It is a waxy, crystalline substance, clear or white in color, which is solid at room temperature and melts slightly above. The main form of menthol occurring in nature is (-)-menthol, which is assigned the (1R,2S,5R) configuration. Menthol has local anesthetic and counterirritant qualities, and it is widely used to relieve minor throat irritation.
Dosage Form	Clotrimazole에 대한 Dosage_Form 정보 Cream IntravaginalCream Topical Crotamiton에 대한 Dosage_Form 정보 Cream Topical Lidocaine에 대한 Dosage_Form 정보 Aerosol TopicalAerosol, metered TopicalCream TopicalGel TopicalJelly TopicalJelly UrethralLiquid BuccalLiquid DentalLiquid InfiltrationLiquid IntravenousLiquid OralLiquid TopicalLotion TopicalOintment TopicalSolution InfiltrationSolution IntramuscularSolution IntravenousSolution OralSolution TopicalSpray TopicalSwab Topical Menthol에 대한 Dosage_Form 정보 Cream TopicalGel TopicalLiquid NasalLiquid OralLiquid TopicalLozenge OralOintment TopicalPatch TopicalPowder TopicalSolution / drops OralSpray Topical
Drug Category	Clotrimazole에 대한 Drug_Category 정보 Anti-Infective Agents, LocalAntifungal AgentsGrowth Inhibitors Crotamiton에 대한 Drug_Category 정보 Antiparasitic AgentsAntipruriticsPesticidesScabicides Lidocaine에 대한 Drug_Category 정보 AnestheticsAnesthetics, LocalAnti-Arrhythmia AgentsAntiarrhythmic Agents Menthol에 대한 Drug_Category 정보 Antipruritics
Smiles String Canonical	Clotrimazole에 대한 Smiles_String_canonical 정보 ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1 Crotamiton에 대한 Smiles_String_canonical 정보 CCN(C(=O)C=CC)C1=CC=CC=C1C Lidocaine에 대한 Smiles_String_canonical 정보 CCN(CC)CC(=O)NC1=C(C)C=CC=C1C Menthol에 대한 Smiles_String_canonical 정보 CC(C)C1CCC(C)CC1O
Smiles String Isomeric	Clotrimazole에 대한 Smiles_String_isomeric 정보 ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1 Crotamiton에 대한 Smiles_String_isomeric 정보 CCN(C(=O)\C=C\C)C1=CC=CC=C1C Lidocaine에 대한 Smiles_String_isomeric 정보 CCN(CC)CC(=O)NC1=C(C)C=CC=C1C Menthol에 대한 Smiles_String_isomeric 정보 CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
InChI Identifier	Clotrimazole에 대한 InChI_Identifier 정보 InChI=1/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H Crotamiton에 대한 InChI_Identifier 정보 InChI=1/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3 Lidocaine에 대한 InChI_Identifier 정보 InChI=1/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)/f/h15H Menthol에 대한 InChI_Identifier 정보 InChI=1/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1
Chemical IUPAC Name	Clotrimazole에 대한 Chemical_IUPAC_Name 정보 1-[(2-chlorophenyl)-di(phenyl)methyl]imidazole Crotamiton에 대한 Chemical_IUPAC_Name 정보 N-ethyl-N-(2-methylphenyl)but-2-enamide Lidocaine에 대한 Chemical_IUPAC_Name 정보 2-diethylamino-N-(2,6-dimethylphenyl)acetamide Menthol에 대한 Chemical_IUPAC_Name 정보 (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol
Drug-Induced Toxicity Related Proteins	DOCA 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:Aquaporin-2 Drug:DOCA Toxicity:hypertension. [바로가기] LIDOCAINE 의 Drug-Induced Toxicity Related Protein정보 Replated Protein:glucose-regulated protein Drug:lidocaine Toxicity:intestinal disorder. [바로가기] Replated Protein:Alkaline phosphatase Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기] Replated Protein:C-reactive protein Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:C-reactive protein Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기] Replated Protein:Alpha-1-acid glycoprotein Drug:lidocaine Toxicity:lidocaine tolerance. [바로가기] Replated Protein:Gamma-glutamyltranspeptidase Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:Alkaline phosphatase Drug:lidocaine Toxicity:fever. [바로가기] Replated Protein:Gamma-glutamyltranspeptidase Drug:lidocaine Toxicity:lidocaine induced hepatitis. [바로가기]

사용자컨텐츠

항목

내용

핵심 요약 정보